Literature DB >> 31659254

ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.

Chengjian Guan1,2,3, Lin He4, Zhenyu Chang2,3, Xinjin Gu2,3, Jing Liang4, Rong Liu5,6.   

Abstract

Discerning oncogenic drivers from passengers remain a major effort in understanding of the essence of the initiation and development of hepatocellular carcinoma (HCC), which is the most common primary liver malignancy and the third leading cause of cancer mortality worldwide. Here we report that ZNF774, a novel zinc-finger protein, inhibits the proliferation and invasion of HCC cells. Molecular characterization of this protein indicated that ZNF774 acts as a transcription repressor, and interrogation of ZNF774 interactome by affinity purification-coupled mass spectrometry revealed that ZNF774 is physically associated with the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex in cells. Genome-wide identification of the transcriptional targets of the ZNF774/NuRD complex by ChIP-seq indicated that ZNF774 represses a cohort of genes including NOTCH2 that are critically involved in the growth and mobility of HCC. We demonstrated that the ZNF774/NuRD complex inhibits the proliferation and invasion of HCC cells in vitro and suppresses HCC growth and metastasis in vivo. Importantly, the expression of ZNF774 is significantly downregulated in HCC, and low ZNF774 expression strongly correlated with high NOTCH2 expression, advanced pathological stages, and poor overall survival of the patients. Together, these results uncover a key role for the ZNF774/NuRD-NOTCH2 axis in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31659254     DOI: 10.1038/s41388-019-1075-0

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  The canonical Notch signaling pathway: unfolding the activation mechanism.

Authors:  Raphael Kopan; Maria Xenia G Ilagan
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 2.  Notch signaling at a glance.

Authors:  Kazuya Hori; Anindya Sen; Spyros Artavanis-Tsakonas
Journal:  J Cell Sci       Date:  2013-05-31       Impact factor: 5.285

Review 3.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

4.  Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.

Authors:  Fabian Geisler; Florian Nagl; Pawel K Mazur; Marcel Lee; Ursula Zimber-Strobl; Lothar J Strobl; Freddy Radtke; Roland M Schmid; Jens T Siveke
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

Review 5.  Notch and cancer: a double-edged sword.

Authors:  U Koch; F Radtke
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

6.  Constitutive Notch2 signaling induces hepatic tumors in mice.

Authors:  Michael T Dill; Luigi Tornillo; Thorsten Fritzius; Luigi Terracciano; David Semela; Bernhard Bettler; Markus H Heim; Jan S Tchorz
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

7.  A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.

Authors:  Apostolos Klinakis; Camille Lobry; Omar Abdel-Wahab; Philmo Oh; Hiroshi Haeno; Silvia Buonamici; Inge van De Walle; Severine Cathelin; Thomas Trimarchi; Elisa Araldi; Cynthia Liu; Sherif Ibrahim; Miroslav Beran; Jiri Zavadil; Argiris Efstratiadis; Tom Taghon; Franziska Michor; Ross L Levine; Iannis Aifantis
Journal:  Nature       Date:  2011-05-12       Impact factor: 49.962

8.  Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.

Authors:  Wei Xiao; Zhiyong Gao; Yixing Duan; Wuxiong Yuan; Yang Ke
Journal:  J Exp Clin Cancer Res       Date:  2017-03-09

9.  Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation.

Authors:  Ikuo K Suzuki; David Gacquer; Roxane Van Heurck; Devesh Kumar; Marta Wojno; Angéline Bilheu; Adèle Herpoel; Nelle Lambert; Julian Cheron; Franck Polleux; Vincent Detours; Pierre Vanderhaeghen
Journal:  Cell       Date:  2018-05-31       Impact factor: 41.582

10.  PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.

Authors:  Helena Serra; Iñigo Chivite; Ana Angulo-Urarte; Adriana Soler; James D Sutherland; Amaia Arruabarrena-Aristorena; Anan Ragab; Radiance Lim; Marcos Malumbres; Marcus Fruttiger; Michael Potente; Manuel Serrano; Àngels Fabra; Francesc Viñals; Oriol Casanovas; Pier Paolo Pandolfi; Anna Bigas; Arkaitz Carracedo; Holger Gerhardt; Mariona Graupera
Journal:  Nat Commun       Date:  2015-07-31       Impact factor: 14.919

View more
  5 in total

1.  Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma.

Authors:  Takuma Nakatsuka; Hayato Nakagawa; Yuki Hayata; Taijiro Wake; Tomoharu Yamada; Mizuki Nishibatake Kinoshita; Ryo Nakagomi; Masaya Sato; Tatsuya Minami; Koji Uchino; Kenichiro Enooku; Yotaro Kudo; Yasuo Tanaka; Takahiro Kishikawa; Motoyuki Otsuka; Ryosuke Tateishi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-03-12       Impact factor: 7.527

Review 2.  Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma.

Authors:  Xinxin Li; Mengzhen Han; Hongwei Zhang; Furong Liu; Yonglong Pan; Jinghan Zhu; Zhibin Liao; Xiaoping Chen; Bixiang Zhang
Journal:  Biomark Res       Date:  2022-01-09

3.  Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival.

Authors:  Andrea Balogh; Lilla Reiniger; Szabolcs Hetey; Peter Kiraly; Eszter Toth; Katalin Karaszi; Kata Juhasz; Zsolt Gelencser; Agnes Zvara; Andras Szilagyi; Laszlo G Puskas; Janos Matko; Zoltan Papp; Ilona Kovalszky; Csaba Juhasz; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

4.  Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress.

Authors:  Ramon Martinez; Weiliang Huang; Ramin Samadani; Bryan Mackowiak; Garrick Centola; Lijia Chen; Ivie L Conlon; Kellie Hom; Maureen A Kane; Steven Fletcher; Paul Shapiro
Journal:  J Pharmacol Exp Ther       Date:  2020-10-27       Impact factor: 4.030

5.  Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma.

Authors:  Qiuli Liang; Chao Tan; Feifei Xiao; Fuqiang Yin; Meiliang Liu; Lei Lei; Liuyu Wu; Yu Yang; Hui Juan Jennifer Tan; Shun Liu; Xiaoyun Zeng
Journal:  Bosn J Basic Med Sci       Date:  2021-12-01       Impact factor: 3.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.